IL6 and neoplasm: This took into account five clinical variables (gender, performance status, forced expiratory volume, number of lymph node stations and tumour volume) (Dehing-Oberije et al., 2009), the performance of this model was improved upon the addition of two blood borne biomarkers CEA and IL-6 (Dehing-Oberije et al., 2011).